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Abstract
The rostroventral medial medulla (RVM) is part of a rapidly acting spino-bulbo-spinal loop that is activated by ascending nociceptive inputs
and drives descending feedback modulation of spinal nociception. In the adult rat, the RVM can facilitate or inhibit dorsal horn neuron
inputsbut in younganimalsdescending facilitationdominates. It is not knownwhether this early life facilitation is part of a feedback loop.We
hypothesized that the newborn RVM functions independently of sensory input, before the maturation of feedback control. We show here
that noxious hind pawpinch evokes no fos activation in theRVMor the periaqueductal gray at postnatal day (P) 4 or P8, indicating a lack of
nociceptive input at these ages. Significant fos activation was evident at P12, P21, and in adults. Furthermore, direct excitation of RVM
neurons with microinjection of DL-homocysteic acid did not alter the net activity of dorsal horn neurons at P10, suggesting an absence of
glutamatergic drive, whereas the same injections caused significant facilitation at P21. In contrast, silencing RVM neurons at P8 with
microinjection of lidocaine inhibited dorsal horn neuron activity, indicating a tonic descending spinal facilitation from the RVM at this age.
The results support the hypothesis that early life descending facilitation of spinal nociception is independent of sensory input. Since it is not
alteredbyRVMglutamatergic receptor activation, it is likely generatedby spontaneousbrainstemactivity.Only later in postnatal life can this
descending activity be modulated by ascending nociceptive inputs in a functional spinal-bulbo-spinal loop.
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Rostroventral medulla, Receptive field
1. Introduction
Spinal dorsal horn sensory inputs and nociceptive reflexes are
modulated by descending brainstem controls45 that underlie the
control of pain by stress, fear, reward, and expectation.6,13,25,44 The
rostroventral medulla (RVM) plays a key role in this process as it
contains neurons that project down to the spinal dorsal horn27,30 and
receive inputs from higher centers such as the insular cortex,47 the
periaqueductal gray (PAG), and parabrachial (PB) nucleus.8,39,55
Nociceptive dorsal horn pathways terminate in the PB nucleus and
PAG (the afferent limb),which in turn activateRVMneuronsprojecting
back to the dorsal horn (the efferent limb) forming a spinal-bulbo-
spinal loop. Descending RVMmodulation in adult animals is biphasic
and can facilitate or inhibit acute spinal nociception16,17,60 in an injury
and context-specific manner.10,38,51,60
In young animals, dorsal horn tactile and nociceptive
circuits are shaped by activity-dependent mechanisms.18,20,32
Periaqueductal gray–RVM modulation of spinal nociceptive
circuits is slow to mature and is predominantly facilitatory until
4 weeks after birth,21,22,33,34 rendering the system vulnerable to
changes in noxious sensory inputs.9,52 However, little is known
about the postnatal development of a functional spinal-bulbo-
spinal loop. We hypothesize that, in the early postnatal period,
descending RVM control of spinal nociception occurs in the
absence of ascending sensory inputs. Only later in life does the
formation of a spinal-bulbo-spinal loop allow sensory modula-
tion of descending controls. We tested this using in vivo
functional mapping and dorsal horn electrophysiology together




All experiments were performed in accordance with the United
Kingdom Animal (Scientific Procedures) Act 1986. Reporting is
based on the Animal Research: Reporting of In Vivo Experiments
guidelines developed by the National Centre for Replacement,
Refinement, and Reduction of Animals in Research, London,
United Kingdom.29 Male and female Sprague-Dawley rats at
various ages from postnatal day (P) 4 to P45 were obtained from
the Biological Services Unit, University College London.
Rats were bred and maintained in house and exposed to the
same caging, diet, and handling throughout development. Litters
were weaned at P21 into same sex cages of 4 littermates and
were housed in 12 hours light/dark cycles at constant ambient
temperature and humidity with free access to water and food.
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2.2. Electrophysiology
Rats were anesthetised with isoflurane (induction 4% in medical
O2), tracheotomized, and artificially ventilated under constant
isoflurane anesthesia (maintenance of 1.8% in medical O2,
Univentor Anaesthesia Unit 400; Royem Scientific, Luton, United
Kingdom). The air flow and breathing rate were adjusted to
the animal’s sizes using a small animal ventilator (model 687;
Harvard Apparatus, MA). Heart rate was constantly monitored by
electrocardiogram. A homeothermic blanket with feedback
control (model 507220F; Harvard Apparatus) and heating lamp
were used to maintain body temperature at physiological levels.
The rat was mounted onto a stereotaxic frame (Kopf Instruments,
Tujunga, CA). A laminectomy was performed to expose the
lumbar spinal cord, the vertebral column was secured with
a clamp to the thoracic site and the dura and pia mater were
removed. A film of mineral oil was used to cover the exposed
spinal cord to prevent heat loss. The skull was exposed and
bregma located to perform a small craniotomy for RVM
microinjection.
2.3. Rostroventral medulla stimulation and silencing
Stereotaxic coordinates for the RVM were calculated as outlined
previously.21 A 26-gauge 10-mL syringe (Hamilton, Reno, NV) was
lowered into the RVM and drug or saline was injected over a 5-
minute period. The experimenter was blinded to the drug
administered. At the end of experiments, animals were terminally
anesthetized with an intraperitoneal injection of an overdose of
pentobarbitone (Euthatal; United Kingdom). The brain was dis-
sected out to allow visual inspection of the injection site. Data from
animalswith injection siteswhich lay outside theRVMwere rejected.
In RVM excitation experiments, the excitatory glutamatergic
analog DL-homocysteic acid (DLH; nonselective N-methyl-D-
aspartate receptor agonist; Sigma-Aldrich, United Kingdom) was
dissolved in Ringer solution and saline to a concentration of 10
mg/mL (1%, pH 6.9). Of note, 0.7 to 1mL of injectate containing 7
to 10 mg (depending on age) of DLH was microinjected into the
RVM. In RVM silencing experiments, lidocaine hydrochloride
monohydrate (Sigma-Aldrich, United Kingdom) was dissolved in
saline to a concentration of 20 mg/mL (2%, pH 5.5). Of note, 0.7
to 1 mL of injectate containing 14 to 20 mg of lidocaine was
microinjected into the RVM. Control animals received equivalent
volumes of saline.
2.4. In vivo extracellular recordings in the dorsal horn
To isolate individual neurones in the dorsal horn, a 6-mm tipped
glass-coated carbon fiber microelectrode (Kation Scientific,
Minneapolis, MN) was lowered through the cord in 2 to 10 mm
steps with a microdrive (Digitimer SCAT-01 microelectrode
stepper system; Digitimer, United Kingdom) while stroking the
plantar surface of the hind paw as a search stimulus for dorsal
horn wide dynamic range (WDR) cells in lamina IV-VI. Cutaneous
receptive fields to brush and pinch stimulation were mapped and
the number of spikes per stimulus to brush, pinch, and von Frey
hair (vFh) stimulation of the receptive field were recorded. Brush
and vFh stimuli were applied for 0.5 seconds and pinch
stimulation for 2 seconds. To avoid sensitization of nociceptors
in younger animals, the maximum vFh force applied to P8-10 rats
was 6.7 g and to P21 and adult rats, it was 9.8 g. Stimulus-
evoked potentials were digitalized using PowerLab 4/30 interface
and isolated using the Chart 5 software spike histogram plug-in
(AD Instruments Ltd, Oxford, United Kingdom).
In RVM activation experiments, one cell was recorded per
animal (P10 n 5 19; P21 n 5 17; and adult n 5 18). A WDR
neuron was isolated and recorded from to establish baseline cell
receptive fields and brush, pinch, and vFh-evoked firing
properties. DL-homocysteic acid was then microinjected into
the RVM and the same train of peripheral stimuli was applied to
the hind paw receptive fields 20 minutes after injection to allow
within-cell changes to be analyzed. A previous study has
demonstrated that the maximum effect of glutamate analog
injection is up to 30 minutes after RVM injection.27
In RVM silencing experiments, lidocaine or saline was micro-
injected into the RVM. Wide dynamic range neuron recordings
were performed 10 minutes after RVM microinjection up to
90 minutes; a timeframe which is within the period of maximal
effect of lidocaine.3 Cell properties were compared as popula-
tions from lidocaine-treated animals (P8522cells from4animals;
P21 5 24 cells from 4 animals; and adult 5 17 cells from 4
animals) and control animals (P85 21 cells from6 animals; P215
28 cells from 4 animals; and adult5 23 cells from 7 animals). The
control cell population is a pooled group of cells from animals
receiving RVM saline (P85 7 cells from 2 animals; P215 15 cells
from 2 animals; and adult 5 13 cells from 2 animal) and naive
animals which displayed the same cell properties.
2.5. Cutaneous pinch stimulation and
fos immunohistochemistry
Animals at P4, P8, P12, P21, and P40 (n 5 4 per age) were
anaesthetized with isoflurane and maintained at a low level of
anesthesia sufficient to cause areflexia (1.8%-2%). The pinch
stimulus was applied with forceps for 5 seconds on 6 points on
both the dorsal and ventral surface of the left hind paw over the
course of 1 minute as previously described.43 Control animals
(n 5 4 per age) received the same length of anesthesia.
Two hours after pinch stimulation/anesthesia, rats were
reanesthetized with pentobarbitone sodium (500 mg/kg) and
perfused transcardially with heparinised saline (5000 IU/mL)
followed by 4%paraformaldehyde in 0.1Mphosphate buffer. The
brain was removed and postfixed overnight in 4% paraformalde-
hyde and transferred to a 30% sucrose solution in 0.1 PB
containing 0.01% azide and stored at 4˚C. Periaqueductal gray,
PB, and RVM tissue were collected in 40mm transverse sections.
Brainstem sectionswere double labeled for c-fos andNeuN. For
c-fos staining, free-floating sections were blocked with 3% goat
serum in 0.3%Triton X-100 in 0.1Mphosphate buffer solution for 1
hour at room temperature. Sectionswere then incubated overnight
at room temperature with rabbit anti–c-fos antibody (1:20,000;
Millipore, Darmstadt, Germany). The next day, sections were
incubated inbiotinylated antirabbit antibody (goat antirabbit; 1:400;
Vector Stain) for 90minutes. Sectionswereplaced inABCcomplex
(1:125; Vector Stain, ABCelite kit; Vector Labs, Burlingame,CA) for
30 minutes, followed by biotinylated tyramide (1:75; TSA Stain Kit;
Perkin Elmer, Waltham, MA) for 7 minutes. Sections were then
incubated in fluorescence isothiocyanate (FITC; 1:600; Vector
Stain) for 2 hours. For double labeling with NeuN, sections were
incubated in mouse anti-NeuN (1:500; Chemicon, Temecula, CA)
overnight before a final 2-hour incubation with goat antimouse
Alexafluor 594 (1:250; Invitrogen, Carlsbad, CA).
2.6. Fos-immunoreactivity cell counting
In immunohistochemistry experiments, the presence of Fos-
immunoreactive (Fos-ir) neurons was examined in the ventrolat-
eral PAG (vlPAG), the PB nucleus, and the RVM. In the PB area,
678 F. Schwaller et al.·157 (2016) 677–686 PAIN®
the spinocerebellar tract, the inferior colliculus, and the brachium
conjunctivumwere usedas landmarks and rostrocaudal distribution
of sections were determined with respect to the reference plane
where the inferior colliculus merges with the pons. Fos-
immunoreactive neurons were counted in the contralateral
mesencephalic PBel and PBsl and the pontine PBel; areas which
are known to receive ascending input from the superficial dorsal
horn in adult studies.11,14,48 In the PAG, Fos-ir neurons were
examined in the contralateral ventrolateral region which receives
ascending input from the spinal dorsal horn28 and includes neurons
that directly project to theRVM55 in adult animals. In theRVM,Fos-ir
cells were counted in the nucleus raphe magnus, lateral para-
gigantocellular nucleus, and gigantocellular reticular nucleus alpha.
2.7. Microsphere injection and visualization
Newborn (P0, n5 4) and P6 (n5 4) rats were anaesthetized with
isoflurane. A laminectomy at lumbar level 4 to 5 was performed
and the dura was incised to expose the spinal dorsal horn.
Microspheres (Retrobeads, Lumafluor, Durham, NC) were
injected into the lumbar dorsal horn using a 2.5-mL Hamilton
syringe fitted with a 28G micropipette. Of note, 0.2 mL of
microsphere solution was injected into the left dorsal horn, after
which the pipette tip was held in the injection site for 1 minute
before withdrawal. The skin was then sutured with 5 to 0 suture
(Ethicon, Somerville, NJ), and Eutectic Mixture of Local Anes-
thetics cream (AstraZeneca, London, United Kingdom) was
applied to the wound before the pupswere returned to their cage.
Animals were perfused as described above 4 days after
intraspinal injection of microspheres (Retrobeads; Lumafluor).
Spinal cord and RVM tissue was taken and collected in 40 mm
transverse sections before blocking in 3%goat serum, incubation
overnight with mouse NeuN (1:500), and fluorescent marking for
2 hours with goat antimouse Alexafluor 594 (1:250).
All sections were mounted on gelatinized slides and were then
cover slipped with Fluoromount (Sigma-Aldrich). Negative control
stains omitting primary antibodies resulted in no immunofluores-
cence, demonstrating no nonspecificity of any protocol. Sections
were viewed using a Leica digital module R light microscope,
photographed using a Hamamatsu C4742-95 digital camera and
analyzed with Volocity software 6.3.
2.8. Statistical analyses
Statistical analyses and graphingwere performed usingGraphPad
Prism 6 (GraphPad software, La Jolla, CA), and P , 0.05 was
considered statistically significant. Sample sizes for testing were
based on previously reported group differences between RVM
silenced/stimulated animals3,33,53 and Fos immunohistochemistry
experiments.2,5 All datasets were normally distributed, therefore
parametric statistical tests were used. Data are represented as
means 6SEM.
In immunohistochemistry experiments, Fos-ir neurons were
counted in 4 to 5 sections per animal, which were averaged to
create one value per animal. The mean pinch-induced Fos-ir and
mean control Fos-ir in each brainstem region were compared at
each age using 2-way analysis of variance (ANOVA) followed by
Bonferroni post hoc multiple comparisons test.
In DLH electrophysiology experiments, single neurons were
followed before and after RVM injection. Neurons were pooled
from each age and group differences at baseline and 20 minutes
after DLH injection tested using paired Student t tests. Individual
cells are shown as facilitated, inhibited, or not changed after
injection, defined as a.10% increase or decrease in firing rate or
receptive field size over baseline. For vFh responses, a 2-way
repeated measured ANOVA were used within the age groups
followed by Bonferroni post hoc multiple comparison, where vFh
force and time points (baseline and 20 minutes after intra-RVM
DLH microinjection) were variables.
In RVM lidocaine electrophysiology experiments, WDR
neurone recordings from lidocaine-treated animals were pooled
and treated as one population of neurones for each age. Data
from naive animals were combined with data from RVM
saline–treated animals as a control group, as there were no
statistical differences between them at any age (data not
shown). Group differences between control and lidocaine-
treated animals within age groups were tested with unpaired
Student t tests and one-way ANOVA followed by Bonferroni
post hoc multiple comparison tests. In vFh experiments, 2-way
ANOVA was used within the age groups followed by Bonferroni
post hoc multiple comparison test to compare differences in
responses to increasing vFh force in control animals and
lidocaine-treated animals.
Dorsal horn neuron receptive fields were drawn on a template
during recording and then imported and expressed as a percent-
age of the total area of the hind paw plantar surface using
Inkscape (version 0.48; www.inkscape.org).
3. Results
3.1. Functional nociceptive inputs to the periaqueductal gray
and rostroventral medulla form at P12
To test the age at which ascending functional nociceptive
connections are formed in the brainstem, and the afferent limb of
the spinal-bulbo-spinal loop is established, noxious-evoked fos
activity was mapped in 3 brainstem regions: the PB nucleus,
vlPAG, and the RVM (Figs. 1A–I). Noxious pinch stimulation of the
hind paw under light anesthesia was applied at different ages from
P4 to P40 and the number of neurons expressing fos in the 3 sites
was counted. Figure 1J shows that in the PB nucleus, the number
of Fos-ir cells significantly increased after noxious hind paw pinch
stimulation compared with control at P12, P21, and in adults
(2-way ANOVAwith Bonferroni post hoc analysis, control vs pinch,
P , 0.05-0.001 at different ages). Although a 2-way ANOVA with
Bonferroni post hoc comparison did not reveal significance at P4
and P8, unpaired Student t tests did demonstrate significantly
increased Fos-ir after pinch compared with control (Fig. 1J). There
was no fos increase in the vlPAG and the RVM after hind paw,
noxious pinch stimulation at P4 or P8 but a significant increase in
the number of Fos-ir cells compared with control at P12, P21, and
in adults (2-way ANOVA with Bonferroni post hoc analysis, control
vs pinch, P, 0.05-0.001 at different ages, Figs. 1K and L). These
findings suggest that the PAG and the RVM system do not receive
noxious ascending input until P12, however the PB nucleus
receives this input earlier within the first postnatal week.
3.2. Direct excitation of rostroventral medulla neurons does
not alter dorsal horn cell activity at P10
We next turned to the descending limb of the spino-bulbar-spinal
loop by testing whether direct excitation of RVM neurons was
able to alter dorsal horn neuron firing properties at young rat pups.
First, we confirmed that RVMneurons project to the lumbar spinal
dorsal horn in newborn rats with retrograde labeling with
intraspinal microinjection of microspheres. Numerous neuronal
cell bodies were retrogradely labeled in the RVM at P4 and P10
after intraspinal microinjection of microspheres into the L4/5
dorsal horn at P0 and P6, respectively (Fig. 2A).
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Next, we tested the age at which direct glutamatergic excitation
of RVM neurons can alter dorsal horn cell activity by microinjecting
the glutamate analog DLH into the RVM and measuring the effect
on the properties of spinal WDR neurons at different ages.
Receptive field sizes and stimulus-evoked spike activity were
recorded before and 20 minutes after DLH microinjection into the
RVM in P10 (n5 19), P21 (n 5 17), and adult (n 5 18) rats.
In P10 rats, the mean pinch-evoked spike activity of WDR
neurons was not significantly different 20 minutes after DLH
compared with baseline (paired t test, baseline vs 20 minutes,
P 5 0.44; Fig. 2B). Similarly, pinch receptive field size was not
significantly different 20 minutes after DLH compared with
baseline (paired t test, baseline vs 20 minutes, P 5 0.46;
Fig. 2C). In P21 rats, RVM DLH microinjection increased the
mean pinch-evoked spike activity (paired t test, baseline vs
20 minutes, P , 0.05; Fig. 2E) and pinch receptive field size
(paired t test, baseline vs 20 minutes, P , 0.01; Fig. 2F). In
contrast, RVM DLH microinjection in adults decreased the mean
pinch-evoked spike activity (paired t test, baseline vs 20 minutes,
P , 0.05; Fig. 2H) and pinch receptive field size (paired t test,
baseline vs 20 minutes, P, 0.01; Fig. 2I). It should be noted that
these mean values reflect “net” changes in the dorsal horn but
that the effects on individual dorsal horn neurons varied (Fig. 2).
Rostroventral medulla DLH microinjection did not change
brush-evoked firing activity (paired t test, baseline vs 20 minutes,
P . 0.05; Figs. 2D, G and J) or brush receptive field sizes (data
not shown) at any age tested. Similarly, DLH microinjection did
not change spontaneous firing activity at any age tested (paired
t test, baseline vs 20 minutes, P. 0.05; data not shown). These
data demonstrate that direct exogenous glutamatergic activation
of RVM neurons does not modulate spinal WDR neuron
nociception at P10 but does do so at P21 and in adult rats. At
Figure 1. Noxious sensory input into the parabrachial (PB) nucleus, the ventrolateral periaqueductal gray (vlPAG), and the rostroventral medulla (RVM) is not
evident before postnatal day (P) 12. Hind paw pinch stimulation causes substantial fos expression in the PB at P8 (A), P12 (B), and P21 (C). In comparison, pinch-
induced fos expression was low in the vlPAG at P8 (D) but was significant at P12 (E) and even more so at P21 (F). Similarly, pinch-induced fos expression was
sparse in the RVM at P8 but was significantly increased at P12 (H) and P21 (I). Quantification of naive and pinch-induced fos expression in the PB nucleus
demonstrated significantly higher fos counts in pinch animals compared with naive animals at P12, P21, and in adults (J). Quantification in the vlPAG (K) and RVM
(L) also demonstrated significantly higher fos counts in pinch animals compared with naive animals at P12, P21, and in adults. Two-way analysis of variance with
Bonferroni post hoc analysis *, **, *** P , 0.05, 0.01, and 0.001 pinch compared with naive within each age. Note the high fos expression in the RVM in naive and
pinch animals alike at P4 (L). Scale bars 5 200 mm.
680 F. Schwaller et al.·157 (2016) 677–686 PAIN®
P21, RVM neurons facilitate spinal nociception, whereas in
adults, they inhibit nociception.
3.3. The rostroventral medulla exerts a tonic facilitation on
dorsal horn neurons from at least P8
The above experiments suggest that before P12, there is no
functional nociceptive input to RVM neurons nor is it possible
to modulate dorsal horn activity on exogenous excitation of
RVM neurons. This suggests that the RVM is not part of a spino-
bulbo-spinal loop at this age. However, it is still possible that
immature RVM neurons provide tonic descending input to the
dorsal horn in the absence of active afferent inputs.We tested this
by silencing RVM neuron activity with microinjection of lidocaine
into the RVM of P8, P21, and adult rats and measuring the effect
on spinal dorsal horn WDR neuron activity. Cutaneous receptive
fields and evoked spike activity of WDR neurons were recorded in
2 groups of animals, RVM lidocaine animals (P8, n 5 22 from
Figure 2. Direct excitation of rostroventral medulla (RVM) neurons by microinjection of DL-homocysteic acid (DLH) has alters dorsal horn neuron activity at
postnatal day (P) 21 and adulthood but not at P10. (A) Intraspinal injections of microspheres at P0 retrogradely labels neurons in the RVM 4 days after injection,
demonstrating that RVM neurons sent axons to the cord from an early age. Scale bars5 200 mm. (B–J) The effect of microinjection of DLH into the RVM on the
activity and receptive field properties of wide dynamic range (WDR) dorsal horn neurons in L4/5. For illustrative purposes, cells in which RVMDLH injection caused
an increase in firing rate or receptive field (RF) size compared with baseline (.10%) are shown in red, cells in which there was a decrease in firing rate or RF size are
shown in blue, cells with no change are in black. At P10, RVMDLH injection did not changeWDRneuron pinch-evoked firing rate (B) and pinch RF size (C) or brush-
evoked firing rate (D) compared with baseline. At P21, mean WDR neuron pinch-evoked firing rate was higher (E) and RF size was larger (F) 20 minutes after RVM
DLH injection compared with baseline. Brush-evoked firing rate was not changed after RVM DLH injection (G). In adult animals, RVM DLH injection decreased
pinch-evoked firing rate (H) and pinch RF size (I) compared with baseline. Brush-evoked firing was not changed after RVMDLH injection (J). Paired Student t test *,
**P , 0.05 and 0.01 RVM DLH microinjection 120 minutes compared with predrug baseline WDR neuron responses.
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4 animals; P21, n5 24 from 4 animals; and adult, n5 17 from 4
animals) and control animals (P8, n5 21 from 6 animals; P21, n5
28 from 4 animals; and adults, n5 23 from 7 animals) in response
to brush, pinch, and vFh stimulation.
In P8 animals, the mean number of spikes per pinch stimulus in
RVM lidocaine animals was significantly lower than control
animals (unpaired Student t test, P , 0.001; Fig. 3A). The mean
pinch receptive field size was also smaller in RVM lidocaine
animals compared with control animals at P8 (unpaired Student
t test, P , 0.05; Fig. 3B). A similar effect of silencing the RVM
was observed at P21. Mean pinch-evoked firing activity
was significantly lower and mean pinch receptive field size was
significantly smaller in RVM lidocaine animals compared with
control animals (unpaired Student t test, P, 0.01 and P, 0.05,
respectively; Figs. 3D and E). In adults, the reverse pattern was
observed: the mean pinch-evoked firing activity was significantly
higher and the mean pinch receptive field size was significantly
larger in RVM lidocaine animals compared with control animals
(unpaired Student t test, P , 0.01 and P , 0.05, respectively;
Figs. 3G and H). Rostroventral medulla lidocaine microinjection
did not significantly affect brush-evoked WDR spike activity
(Figs. 3C, F and I) or brush receptive field sizes (data not shown)
comparedwith control at any age tested. Similarly, RVM lidocaine
microinjection did not significantly affect spontaneous firing
activity when comparedwith control at any age (unpaired Student
t test, P . 0.05; data not shown).
Next, calibrated vFhs were applied to hind paw receptive fields of
WDR neurons in RVM lidocaine animals and control animals.
Comparison of stimulus response curves between RVM lidocaine
and control animals at P8 revealed no significant effect of RVM
lidocaine microinjection on vFh-evoked firing activity (2-way ANOVA
withBonferroni post hocanalysis, control vs lidocaine, F1,2950.378,
P 5 0.543; Fig. 4A). At P21, vFh-evoked firing activity was
significantly lower in RVM lidocaine animals than control animals
(2-way ANOVA, control vs lidocaine, F1,47 5 8.488, P , 0.01;
Fig. 4B). Bonferroni post hoc analysis revealed significant differ-
ences between RVM lidocaine and control cells at 1.1, 1.6, 6.7, and
9.8 g vFhs (2-way ANOVAwith Bonferroni post hoc analysis, control
vs lidocaine, P, 0.01-0.05 at different vFh forces; Fig. 4B). In adult
animals, RVM silencing did not alter vFh-evoked firing activity
compared with control (2-way ANOVA with Bonferroni post hoc
analysis, control vs lidocaine, F1,35 5 1.361, P5 0.251; Fig. 4C).
Figure 3. Focal microinjection of lidocaine in the rostroventral medulla (RVM) alters pinch-evoked dorsal horn cell activity at all ages. At postnatal day (P) 8, RVM
lidocaine injection reduced the mean wide dynamic range (WDR) neuron pinch-evoked firing rate (A) and pinch receptive field (RF) size (B) but not brush-evoked
firing rate (C) compared with age-matched control. Much the same occurred at P21 (D–F). In adult animals, RVM lidocaine injection increased pinch-evoked firing
rate (G) and pinch receptive field size (H) but did not change brush-evoked firing rate (I) compared with control. Unpaired Student t test *, **, ***P, 0.05, 0.01, and
0.001 compared with age-matched control WDR neuron population responses.
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These data demonstrate that at P8, there is a background,
tonic RVM facilitation of noxious pinch responses of spinal WDR
neurons. This facilitation is also present at P21 but is more
extensive and has changed to inhibition in adult animals.
4. Discussion
The data presented here support the hypothesis that the efferent,
descending limb of the spinal-bulbo-spinal loop arising from the
RVM is functionally active at P8, before RVM neurons are
influenced by ascending inputs. In this early postnatal period,
RVM descending control on dorsal horn neurons is independent of
noxious sensory input to the RVM. At P8, silencing RVM neurons
by focal injection of lidocaine revealed a facilitatory role of the RVM
on spinal dorsal horn neurons, but interestingly, this descending
control did not require ascending or exogenous recruitment of the
RVM, as hind paw pinch stimulation failed to increase c-fos
expression in the vlPAG andRVM at P8, and glutamate stimulation
of the RVM at P10 failed to modulate spinal dorsal horn neuron
activity. In contrast, RVM descending control at P21 and in adult
rats can be driven by RVM neuron activation; be it as part of
a functional spino-bulbo-spinal loop by peripheral noxious
stimulation or by focal application of a glutamate analog. We also
show, as described previously, that net RVM descending control
over dorsal horn neurons is facilitatory in young animals and
inhibitory in adult animals but targets nociceptive input at all ages.
These conclusions are limited to cutaneous mechanical sensory
inputs, but these are especially relevant to normal postnatal life.
Endogenous descending control of nociceptive activity is an
important aspect of central nervous system pain processing. In
adults, a change in balance of excitatory and inhibitory drive from
theRVMcan stronglymodulate spinal dorsal horn sensory inputs in
acute and chronic pain states. A rapid feedback loop, driven by
ascending pathways from the spinal dorsal horn and acting
through the PAG-RVM, is vital in moment-to-moment modulation
of nociceptive inputs.49 The apparent dichotomy of facilitation and
inhibition is not a simple “on–off” mechanism, but rather a system
where inhibition and facilitation can operate in parallel to produce
a balanced net outcome which is appropriate to a particular
situation.10,50,51,56 In young animals, this balance is not yet
achieved and descending output is predominantly facilitatory.
Here, we silenced neural activity in the RVM (neurons and fibers
of passage) by focally injecting lidocaine into the RVM at different
ages to investigate the endogenous andongoing role of theRVM in
modulating dorsal horn sensory inputs during postnatal develop-
ment. At P8 and P21, silencing the RVM-reduced pinch-evoked
dorsal horn neuron excitability, demonstrating that in young
animals the RVM exerts a net facilitation of nociceptive inputs
onto dorsal horn WDR neurons. This is consistent with lesions to
the RVM which unmask descending facilitation of behavioral
nociception as young as P3.21 Silencing of RVM neurons by focal
injection of lidocaine has previously been shown to inhibit activity in
some and facilitates activity in most individual neurons in adult
rats,3 however we found that silencing the RVM in uninjured adult
rats increased net dorsal horn neuron excitability, unmasking a net
inhibition of spinal nociception.Others haveused this typeof overall
output analysis to show reduced injury-induced behavioral
hypersensitivity after PAG-RVM silencing with lidocaine, demon-
strating a net descending facilitation during pain states.10,31,40
Electrical stimulation of descending brainstem nuclei has been
extensively used to investigate functional control over dorsal horn
sensory inputs23,45; however, nonselective activation of neigh-
boring neurons and fibers of passage can confound results. In
this study, we selectively activated RVM neurons by injecting the
Figure 4. Focal microinjection of lidocaine into the rostroventral medulla (RVM) has age-dependent effects on von Frey hair (vFh) stimulus response relationships in
dorsal horn neurons. (A) At postnatal day (P) 8, RVM lidocaine injection did not change vFh-evoked firing rates at any force applied. (B) At P21, RVM lidocaine
injection reduced wide-dynamic-range (WDR) firing rates when 1.1, 1.6, 6.7, and 9.8 g vFhs were applied, when compared with control responses. (C) In adult
animals, RVM lidocaine injection did not change vFh-evoked firing rates at any fore applied compared with control. Two-way analysis of variance with Bonferroni
post hoc analysis *, **, ***P, 0.05, 0.01, and 0.001 compared with age-matched control WDR neuron population responses. Injection sites for each age for RVM
lidocaine and RVM DL-homocysteic acid experiments are shown in (D).
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glutamate analog DLH into the RVM and compared individual
dorsal horn neuronal changes before and after injection.
DL-homocysteic acid stimulation of the RVM at P21 strongly
increased pinch-induced excitability of most dorsal horn neurons
and DLH stimulation of the RVM in adult animals decreased
pinch-induced excitability of most dorsal horn neurons. In
accordance with previous RVM electrical stimulation experi-
ments,15,21,33 descending facilitation dominates at P21 and
inhibition dominates in adults, however smaller population of
neurons were also inhibited and facilitated at P21 and in adults,
respectively. However, DLH stimulation of the RVM at P10 did not
change dorsal horn neuron activity; although small subpopula-
tions of dorsal horn neurons were inhibited or excited after
peripheral stimulation; the excitability of most neurons was not
changed by RVM stimulation, suggesting that the RVM neurons
are not easily excited by exogenous stimulation at P10.
Peripheral noxious stimulation increases c-fos expression in the
spinal cord and in nuclei which receive ascending nociceptive input
such as the PBnucleus and thePAG.4,26,28 Neuronal activation, as
measured by increased c-fos or phosphorylated extracellular
signal-related kinase expression, has also been observed in the
adult RVM after peripheral noxious stimulation or injury.19,41,42
Pinch and touch-induced c-fos expression has been reported in
the dorsal horn at P3 and P10, and pinch-selective c-fos
expression is apparent by P21.26 In contrast, formalin injection
only increases c-fos expression in the PAG and thalamus at P14
and not at P3,2 suggesting later development of functional
connections between the spinal dorsal horn and midbrain
projection targets. Here, we show that hind paw pinch stimulation
increases c-fos expression in the PB nucleus from P8. In contrast,
pinch-induced c-fos expression only increased in the vlPAG and
RVM after P12, suggesting that functional development of the
ascending, afferent component of the spino-bulbo-spinal loop is
later to mature than the descending component. Indeed, distal
pinch stimulation can reduce spinal c-fos expression induced by
heterotopic formalin injection at P21 but not at P12, suggesting
functional diffuse noxious inhibitory control from P21 but not at
P12.7 Moreover, injection of them-opioid receptor agonist [D-Ala2,
N-MePhe4, Gly-ol]-enkephalin into the PAG fails to change spinal
reflex excitability in P10 rats.34 These findings parallel the lack of
overall modulation of dorsal horn neuron excitability after gluta-
matergic RVM neuron activation in P10 rats. Hence, adult-like
recruitment of the spino-bulbo-spinal loop by peripheral noxious
stimulation is not observed until the third postnatal week.
Despite this, our RVM silencing experiments at P8 demon-
strated that there is an ongoing overall descending facilitation that
does not require bottom-up or top-down recruitment, is
seemingly selective to noxious inputs, and does not modulate
the spontaneous activity of dorsal horn neurons. Without the
capacity to be recruited by feedforward activation, the immature
RVM would presumably be intrinsically active. Indeed, we
observed fos activation in the RVM in the absence of noxious
stimulation at P4 which may suggest the presence of spontane-
ously active neurons in the RVM at this age.54 Spontaneously
firing “pacemaker” neurons have been well described in the
neonatal rat spino-bulbo-spinal loop in the superficial spinal
dorsal horn.1,35,36 These intrinsically bursting neurons may
function to provide endogenous excitation of developing noci-
ceptive circuits early in development. Although the presence of
age-specific pacemaker neurons has not been identified in the
neonatal RVM, patch-clamp experiments have demonstrated
that most RVM neurons in adult brainstem slices do not exhibit
spontaneous firing activity as frequently observed in RVM
neurons in P10 to 21 brainstem slices.37 Several other studies
have also demonstrated multiple subpopulations of locally and
spinally projecting RVM neurons in brainstem slices of P21 or
younger rats that readily display spontaneous firing activity,57–59
however few studies have directly compared RVM neuronal
properties in young and adult animals. Spontaneous firing activity
is not a property exclusive to neonatal RVM neurons, as baseline
firing activity is a hallmark property of RVM “on” and “off” cells
recorded from anesthetized and awake adult rats.12,16,17,24
In both the RVM glutamatergic activation and lidocaine
silencing experiments, we demonstrate that the net function of
the RVM is inhibitory in uninjured adult rats. These findings are in
accordance with previous studies that have demonstrated
a switch from net facilitation to inhibition between P21 and
P40.21,22,33,34 This switch from facilitation from inhibition is
dependent on sufficient levels of endogenous opioids in the
RVM, as blocking opioidergic activity between P21 and P28
prevents the normal maturation of descending inhibition.22
Indeed, substantial changes in endogenous opioid signaling take
place in the PAG and dorsal horn throughout development which
may underlie the opioid-mediated maturation.34 Ingram and
colleagues have identified late maturation of endocannabinoid
control of RVM GABAergic neurotransmission,37 which could
also contribute to maturation of descending inhibition. Addition-
ally, brainstem dorsal raphe serotonergic neuron lack 5-HT1A
autoreceptor and gamma-aminobutyric acid-mediated inhibition
until .P21, thus driving increased neuronal excitability in young
rats.46 The data suggest that in the first 2 weeks of postnatal life,
an intrinsic and ongoing descending drive from the RVM
facilitates spinal dorsal horn sensory circuitry. This is likely to be
of key importance in amplifying sensory inputs required for
activity-dependent maturation of spinal circuitry. Moreover,
Figure 5.Proposedmodel of the delayedmaturation of the spinal-bulbo-spinal
loop. At postnatal day (P) 8-10, ascending nociceptive inputs from the dorsal
horn (black) are beginning to activate neurons in the parabrachial (PB) nucleus
(solid blue line). However, nociceptive connections to the periaqueductal gray
(PAG) are not functional at this age (dotted blue line). The rostroventral medulla
(RVM) projects to the spinal dorsal horn and modulates dorsal horn neuron
activity (solid red line) but does not receive excitatory glutamatergic inputs from
the PAG or elsewhere to complete the loop (dotted red lines). Therefore, at P8-
10, descending RVM modulation of spinal dorsal horn activity acts in-
dependently of ascending sensory inputs.
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amplified ascending connections from the dorsal horn may
provide the excitatory drive required for maturation of the spino-
bulbo-spinal loop and pain circuits in the brain.
Figure 5 illustrates our proposal that descending facilitatory
control of spinal noxious activity in the early postnatal period
arises from spontaneous activity within the RVM and only later in
development can this descending activity be modulated by
ascending sensory inputs in a spinal-bulbo-spinal loop. The
delayed development of sensory feedback control is likely to
render the immature nervous system more vulnerable to
excessive sensory inputs or peripheral injury.
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